Elevated levels of plasma phenylalanine in schizophrenia: a guanosine triphosphate cyclohydrolase-1 metabolic pathway abnormality? - Wikidata - awgldk - TriplyDB

Elevated levels of plasma phenylalanine in schizophrenia: a guanosine triphosphate cyclohydrolase-1 metabolic pathway abnormality?

Elevated levels of plasma phenylalanine in schizophrenia: a guanosine triphosphate cyclohydrolase-1 metabolic pathway abnormality?

http://www.wikidata.org/entity/Q37500605

about

Blood Levels of Monoamine Precursors and Smoking in Patients with Schizophrenia.Reciprocal moderation by Toxoplasma gondii seropositivity and blood phenylalanine - tyrosine ratio of their associations with trait aggression.

P2860

Q30374523-608AED26-ECF3-42D0-8DC8-B46DAA7ABF36 Q47614659-DC4E6C86-F206-491B-BAB5-91BFD3815695

P2860

Elevated levels of plasma phenylalanine in schizophrenia: a guanosine triphosphate cyclohydrolase-1 metabolic pathway abnormality?

http://www.wikidata.org/entity/Q37500605

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 21 January 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Elevated levels of plasma phen ...... metabolic pathway abnormality?

@en

Elevated levels of plasma phen ...... metabolic pathway abnormality?

@nl

type

label

Elevated levels of plasma phen ...... metabolic pathway abnormality?

@en

Elevated levels of plasma phen ...... metabolic pathway abnormality?

@nl

prefLabel

Elevated levels of plasma phen ...... metabolic pathway abnormality?

@en

Elevated levels of plasma phen ...... metabolic pathway abnormality?

@nl

P1433

Q37500605-4E71D80F-2C50-4EF9-A762-A13D3BEA62D6

P1476

Q37500605-9210C083-5ACF-4FA8-A303-4858919C8C0E

P2093

Q37500605-110735DA-3E0B-4BB3-B635-E58002B1277B

Q37500605-137CE42F-50C2-4E25-BC8F-E62CA70917A9

Q37500605-48F7B782-690B-4D9E-A9AD-ADF7459C961F

Q37500605-5786A470-3224-48BA-9C05-981BDC4AD137

Q37500605-65B42A0B-35BF-440D-AE7A-8F007B69922C

Q37500605-6AF00B26-115E-4286-BA59-D6C0275C55B6

Q37500605-751E497F-27EB-4375-B56F-5E9E06C1CFF4

Q37500605-79FCA574-A4BE-4C1E-ACE7-66FE9A6EE553

Q37500605-7BC9D8EA-3D88-4A44-B245-8F75CC64FE8E

Q37500605-8C839629-5947-46B8-8A3B-4E08F1F80543

P2860

Q37500605-03C9564F-0348-4267-B1D3-2D59E0D687FC

Q37500605-09A376D9-262A-479C-85C2-71D31F57632C

Q37500605-09A47DDB-2CF7-4F7C-8B1F-1CCDD65BCAFA

Q37500605-450D8FB3-1E21-4A64-9620-916DA597705A

Q37500605-4991A822-EDC8-405E-BF10-12A248C7CCB5

Q37500605-53B1AFAA-34B7-46BB-B58A-870E06D7F4AF

Q37500605-572EFCFD-083B-490A-9B24-B6B036A402CE

Q37500605-5B5634C8-0607-42E2-AF2D-A3F3E3535FBC

Q37500605-63F6F734-9C9D-41FA-AEAE-FCA03A800D39

Q37500605-6752709C-18AD-4B2B-8341-9E81640710E6

P304

Q37500605-6A597C0B-6DC0-4B78-991B-4FF6FDEAA44D

P31

Q37500605-923A3856-B97F-4073-87E1-97DA7378AFB5

P356

Q37500605-ABE9BDF9-5062-4332-A28A-07427E4055CD

P407

Q37500605-27BACD4C-14B0-4DB9-8B86-EFEE87319A39

P433

Q37500605-9CCC9509-EE66-491A-828D-0926F748346F

P478

Q37500605-ED4225F7-1B5A-4E2A-AC7D-34EA871DB16C

P50

Q37500605-093017B7-A7E0-4D38-B269-6ACF0FBC19F5

Q37500605-3F4B3DD9-75CF-49C3-AA5E-15FA2A211BCC

Q37500605-70CC384D-0ED1-40D4-BEC5-A1E3E3307543

Q37500605-B2FCCF33-B73E-4791-96A9-B4DB849ED157

Q37500605-F34055D0-392A-470D-95AA-E796DEAB0F2F

P577

Q37500605-244289C8-C7ED-4652-836F-A933F6714ABD

P5875

Q37500605-A4E28127-2FAC-401D-A3C7-8A086D90A193

P698

Q37500605-06E1E510-485F-4047-931E-7138067BD18B

P921

Q37500605-31F4EC4B-39C3-4D47-A5B7-4261BC9BE22E

P932

Q37500605-A8B47970-976A-4958-B390-7D53496BB3CD

P356

JOURNAL.PONE.0085945

P1433

P1476

Elevated levels of plasma phen ...... metabolic pathway abnormality?

@en

P2093

Annette M Hartmann

http://www.w3.org/2001/XMLSchema#string

Ayesha Ashraf

http://www.w3.org/2001/XMLSchema#string

Bettina Konte

http://www.w3.org/2001/XMLSchema#string

Dietmar Fuchs

http://www.w3.org/2001/XMLSchema#string

Elliot Hong

http://www.w3.org/2001/XMLSchema#string

Gloria Reeves

http://www.w3.org/2001/XMLSchema#string

Jason Schiffman

http://www.w3.org/2001/XMLSchema#string

Marion Friedl

http://www.w3.org/2001/XMLSchema#string

Maureen Groer

http://www.w3.org/2001/XMLSchema#string

Olesja Muravitskaja

http://www.w3.org/2001/XMLSchema#string

P2860

The dopamine hypothesis of schizophrenia: version III--the final common pathway

The positive and negative syndrome scale (PANSS) for schizophrenia

Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects

Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin.

Elevated plasma phenylalanine in severe malaria and implications for pathophysiology of neurological complications.

Diurnal variations in plasma concentrations of basic and neutral amino acids and in red cell concentrations of aspartate and glutamate: effects of dietary protein intake.

Antidopaminergic effects of dietary tyrosine depletion in healthy subjects and patients with manic illness.

Dynamic regulation of phenylalanine hydroxylase by simulated redox manipulation

Neopterin as a marker for immune system activation.

13C-phenylalanine breath test detects altered phenylalanine kinetics in schizophrenia patients.

P304

e85945

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0085945

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Olaoluwa Okusaga

Teodor T Postolache

P577

2014-01-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259919897

http://www.w3.org/2001/XMLSchema#string

P698

24465804

http://www.w3.org/2001/XMLSchema#string

P921

P932

3897774

http://www.w3.org/2001/XMLSchema#string